{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:34:00Z","timestamp":1793414040884,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-breast-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.clbc.2024.04.012","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T01:44:33Z","timestamp":1714700673000},"page":"501-509.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multicenter Study on the Frequency of Low Bone Mineral Density in Young Women With Breast Cancer and Associated Factors"],"prefix":"10.1016","volume":"24","author":[{"given":"Fernanda","family":"Mesa-Chavez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanin","family":"Chavarri-Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adara Valeria","family":"L\u00f3pez-Covarrubias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Elena","family":"Mayette-Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Ruiz-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher Jes\u00fas","family":"del R\u00edo-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Guadalupe","family":"Bermudez-Barrientos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Samayoa-Mateos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra Gabriela","family":"Manzanares-Castellanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brizio","family":"Moreno-Jaime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Vega-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Alberto","family":"Tenorio-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3587-339X","authenticated-orcid":false,"given":"Cynthia","family":"Villarreal-Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clbc.2024.04.012_bib0001","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1200\/JCO.2015.64.3809","article-title":"American Cancer Society\/American Society of Clinical Oncology breast cancer survivorship care guideline","volume":"34","author":"Runowicz","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2024.04.012_bib0002","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.annonc.2022.07.007","article-title":"ESO\u2013ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)","volume":"33","author":"Paluch-Shimon","year":"2022","journal-title":"Ann Oncol"},{"issue":"14","key":"10.1016\/j.clbc.2024.04.012_bib0003","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1200\/JCO.2001.19.14.3306","article-title":"Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer","volume":"19","author":"Shapiro","year":"2001","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2024.04.012_bib0004","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.ctrv.2012.02.008","article-title":"Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention?","volume":"38","author":"Hadji","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.clbc.2024.04.012_bib0005","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00198-003-1508-y","article-title":"Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF)","volume":"14","author":"Fogelman","year":"2003","journal-title":"Osteoporos Int"},{"issue":"7","key":"10.1016\/j.clbc.2024.04.012_bib0006","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2005.02.7102","article-title":"Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group","volume":"25","author":"Gnant","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2024.04.012_bib0007","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3389\/fonc.2020.00366","article-title":"Effect of tamoxifen on the risk of osteoporosis and osteoporotic fracture in younger breast cancer survivors: a nationwide study","volume":"10","author":"Lee","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.clbc.2024.04.012_bib0008","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1200\/JCO.2004.08.148","article-title":"Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy","volume":"22","author":"Sverrisdottir","year":"2004","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2024.04.012_bib0009","first-page":"767","article-title":"Bone loss during neoadjuvant\/adjuvant chemotherapy for early stage breast cancer: a retrospective cohort study","volume":"8","author":"Tang Axelsen","year":"2018","journal-title":"Mol Clin Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2024.04.012_bib0010","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1200\/JCO.2005.02.3515","article-title":"Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status","volume":"24","author":"Vehmanen","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2024.04.012_bib0011","first-page":"1135","article-title":"Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial","volume":"9","author":"Cuzick","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.clbc.2024.04.012_bib0012","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1200\/JCO.2006.08.8617","article-title":"Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98","volume":"25","author":"Coates","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2024.04.012_bib0013","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0140-6736(07)60200-1","article-title":"Survival and safety of exemestane versus tamoxifen after 2-3 years\u2019 tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial","volume":"369","author":"Coombes","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.clbc.2024.04.012_bib0014","first-page":"1","article-title":"Assessment of osteoporosis at the primary health care level","volume":"12","author":"Kanis","year":"2007","journal-title":"World Health"},{"key":"10.1016\/j.clbc.2024.04.012_bib0015","unstructured":"International Society for Clinical Densitometry. 2019 ISCD official positions: adult. Available at: https:\/\/iscd.org\/learn\/official-positions\/adult-positions\/ (2019). (Accessed: April 9, 2024)"},{"key":"10.1016\/j.clbc.2024.04.012_bib0016","doi-asserted-by":"crossref","first-page":"P4","DOI":"10.1158\/1538-7445.SABCS18-P4-16-10","article-title":"Abstract P4-16-10: bone health in young women with breast cancer","volume":"79","author":"Wendell","year":"2019","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.clbc.2024.04.012_bib0017","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13058-018-1061-4","article-title":"Evaluation of osteopenia and osteoporosis in younger breast cancer survivors compared with cancer-free women: a prospective cohort study","volume":"20","author":"Ramin","year":"2018","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2024.04.012_bib0018","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S1470-2045(08)70204-3","article-title":"Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy","volume":"9","author":"Gnant","year":"2008","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2024.04.012_bib0019","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10549-014-2928-4","article-title":"Long-term risk of medical conditions associated with breast cancer treatment","volume":"145","author":"Hill","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"18","key":"10.1016\/j.clbc.2024.04.012_bib0020","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1016\/j.ejca.2009.09.026","article-title":"The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer","volume":"45","author":"Hadji","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2024.04.012_bib0021","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1159\/000506465","article-title":"Bone health in premenopausal Chinese patients after adjuvant chemotherapy for early breast cancer","volume":"15","author":"Yip","year":"2020","journal-title":"Breast Care (Basel)"},{"key":"10.1016\/j.clbc.2024.04.012_bib0022","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12018-009-9064-4","article-title":"T-scores and Z-scores","volume":"8","author":"Carey","year":"2010","journal-title":"Clin Rev Bone Mineral Metabol"},{"key":"10.1016\/j.clbc.2024.04.012_bib0023","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3949\/ccjm.88a.20199","article-title":"DXA and clinical challenges of fracture risk assessment in primary care","volume":"88","author":"Williams","year":"2021","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.clbc.2024.04.012_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2019.100254","article-title":"Incidence of fractures in young women with breast cancer\u2014a retrospective cohort study","volume":"18","author":"Stumpf","year":"2019","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.clbc.2024.04.012_bib0025","doi-asserted-by":"crossref","first-page":"394","DOI":"10.21149\/12161","article-title":"Vitamin D status in Mexican women at reproductive age, Ensanut 2018-19","volume":"63","author":"Contreras-Manzano","year":"2021","journal-title":"Salud Publica Mex"},{"issue":"1","key":"10.1016\/j.clbc.2024.04.012_bib0026","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejogrb.2011.06.033","article-title":"Comparison of the acute alterations in serum bone turnover markers and bone mineral density among women with surgical menopause","volume":"159","author":"Bahar","year":"2011","journal-title":"Eur J Obst Gynecol Reprod Biol"},{"key":"10.1016\/j.clbc.2024.04.012_bib0027","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.annonc.2020.03.284","article-title":"ESO\u2013ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)","volume":"31","author":"Paluch-Shimon","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2024.04.012_bib0028","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1359\/jbmr.2003.18.5.900","article-title":"Fracture risk after bilateral oophorectomy in elderly women","volume":"18","author":"Melton","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1016\/j.clbc.2024.04.012_bib0029","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1470-2045(10)70257-6","article-title":"Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial","volume":"11","author":"Cuzick","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2024.04.012_bib0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/13697137.2015.1100383","article-title":"Management of bone disease in women after breast cancer","volume":"18","author":"Milat","year":"2015","journal-title":"Climacteric"},{"key":"10.1016\/j.clbc.2024.04.012_bib0031","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10549-020-05566-w","article-title":"Changes in bone mineral density during 5 years of adjuvant treatment in premenopausal breast cancer patients","volume":"180","author":"Kim","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2024.04.012_bib0032","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.3390\/cancers12113094","article-title":"Osteoporosis: a long-term and late-effect of breast cancer treatments","volume":"12","author":"Shapiro","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clbc.2024.04.012_bib0033","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1016\/S0959-8049(01)00317-3","article-title":"Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment","volume":"37","author":"Vehmanen","year":"2001","journal-title":"Eur J Cancer"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820924001125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820924001125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T10:03:49Z","timestamp":1722074629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820924001125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1526820924001125"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2024.04.012","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multicenter Study on the Frequency of Low Bone Mineral Density in Young Women With Breast Cancer and Associated Factors","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2024.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}